Serum lactate dehydrogenase alone is not a helpful prognostic factor in resected colorectal cancer patients

[1]  Heng Zhao,et al.  LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma , 2013, Tumor Biology.

[2]  Li Li,et al.  Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas , 2012, Clinical Cancer Research.

[3]  Janet E Brown,et al.  Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients , 2012, Clinical Cancer Research.

[4]  A. Armstrong,et al.  Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Garbe,et al.  Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis , 2012, British Journal of Cancer.

[6]  E. Maccaroni,et al.  Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients , 2012, British Journal of Cancer.

[7]  K. Thierauch,et al.  LDH-A influences hypoxia-inducible factor 1α (HIF1 α) and is critical for growth of HT29 colon carcinoma cells in vivo , 2011, Targeted Oncology.

[8]  A. Harris,et al.  Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy , 2011, Clinical Cancer Research.

[9]  N. Kaplan,et al.  Lactate dehydrogenases: structure and function. , 2006, Advances in enzymology and related areas of molecular biology.

[10]  A. Harris,et al.  Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  F. Tas,et al.  Serum Lactate Dehydrogenase Levels at Presentation Predict Outcome of Patients With Limited‐Stage Small‐Cell Lung Cancer , 2001, American journal of clinical oncology.

[12]  N. Nishimura,et al.  Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma. , 2013, Japanese journal of clinical oncology.

[13]  Steven J. Steindel,et al.  4 Lactate Dehydrogenase , 1975 .